Manchester Management Seeks Changes at Vermillion to Protect Shareholder Value | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A Boston-based hedge fund that holds a nearly 10 percent stake in Vermillion is seeking to make changes to the firm's bylaws in order to give shareholders a louder voice in the company and hold management more accountable, according to a letter it has sent to Vermillion executives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.